High Survivin Levels Predict Poor Clinical Response to Infliximab Treatment in Patients with Rheumatoid Arthritis (Q60194288)
Jump to navigation
Jump to search
scientific article published on 28 October 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High Survivin Levels Predict Poor Clinical Response to Infliximab Treatment in Patients with Rheumatoid Arthritis |
scientific article published on 28 October 2011 |
Statements
High survivin levels predict poor clinical response to infliximab treatment in patients with rheumatoid arthritis (English)
Anniella Isgren
Kristina Forslind
Carl Axelsson
Anneli Lund